leucine has been researched along with Chronic Kidney Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 5 (41.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, A; Dong, Q; Feng, L; Fu, M; Lan, Z; Li, L; Li, Y; Liang, Q; Liu, X; Lu, L; Wang, S; Xie, L; Yan, J; Yang, X; Ye, Y | 1 |
| Amaya-Garrido, A; Feuillet, G; Gayral, S; Grzesiak, L; Klein, J; Laffargue, M; Malet, N; Ramel, D; Sarthou, MK; Schanstra, JP; Swiader, A; Wahart, A | 1 |
| Chen, DS; Chen, PJ; Kao, JH; Lin, WT; Liu, CH; Liu, CJ; Peng, CY; Su, TH; Tseng, TC; Yang, SS | 1 |
| Berg, T; Heyne, R; John, C; Klinker, H; Naumann, U; Niederau, C; Serfert, Y; Stein, K; Stoehr, A; Teuber, G; Wiegand, J; Zeuzem, S | 1 |
| Dronamraju, D; Kwo, P | 1 |
| Bräu, N; Brown, A; Collins, C; Colombo, M; Gane, E; Kosloski, M; Lawitz, E; Lei, Y; Leroy, V; Mensa, FJ; Moreno, C; Nelson, DR; Papatheodoridis, G; Persico, M; Pol, S; Pugatch, D; Yoshida, EM | 1 |
| Collins, MG; Kort, J; Kosloski, MP; Liu, W; Marbury, TC; Mensa, F; Preston, RA; Pugatch, D; Zhao, W | 1 |
| Fabrizi, F; Messa, P | 1 |
| Bondin, M; Cacoub, P; Fabrizi, F; Negro, F | 1 |
| Liu, W; Lovell, S; Mensa, FJ; Pilot-Matias, T | 1 |
| Abe, H; Aizawa, Y; Akahane, T; Atsukawa, M; Fukunishi, S; Genda, T; Hotta, N; Ikegami, T; Iwakiri, K; Kondo, C; Kumada, T; Michitaka, K; Nakamuta, M; Nozaki, A; Ogawa, C; Shima, T; Shimada, N; Tachi, Y; Takaguchi, K; Tanaka, Y; Toyoda, H; Tsubota, A; Tsuji, K; Uojima, H; Watanabe, T | 1 |
| Bitla, AR; Kumar, MA; Kumar, VS; Manohar, SM; Narasimha, SR; Raju, KV | 1 |
3 review(s) available for leucine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Managing hepatitis C therapy failures and chronic kidney disease.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Benzofurans; Cardiovascular Diseases; Cyclopropanes; Drug Combinations; Hepatitis C, Chronic; Humans; Imidazoles; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Sulfonamides; Treatment Failure | 2018 |
Expert opinion on the management of renal manifestations of chronic HCV infection.
Topics: 2-Naphthylamine; Amides; Aminoisobutyric Acids; Anilides; Antiviral Agents; Benzimidazoles; Benzofurans; Carbamates; Cyclopropanes; Disease Management; Drug Therapy, Combination; Expert Testimony; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Practice Guidelines as Topic; Proline; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Risk Factors; Ritonavir; Sulfonamides; Uracil; Valine | 2018 |
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Fibrosis; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Leucine; Proline; Protease Inhibitors; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Sulfonamides; Treatment Outcome | 2019 |
3 trial(s) available for leucine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment.
Topics: Adult; Aged; Aged, 80 and over; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Combinations; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Proline; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; RNA, Viral; Sulfonamides; Viral Load | 2017 |
Effects of Renal Impairment and Hemodialysis on the Pharmacokinetics and Safety of the Glecaprevir and Pibrentasvir Combination in Hepatitis C Virus-Negative Subjects.
Topics: Adult; Aged; Aminoisobutyric Acids; Antiviral Agents; Area Under Curve; Benzimidazoles; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Hepacivirus; Hepatitis C; Humans; Kidney Failure, Chronic; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Proline; Pyrrolidines; Quinoxalines; Renal Dialysis; Renal Insufficiency, Chronic; Sulfonamides | 2018 |
The efficacy and safety of glecaprevir plus pibrentasvir in 141 patients with severe renal impairment: a prospective, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Male; Middle Aged; Proline; Prospective Studies; Pyrrolidines; Quinoxalines; Renal Dialysis; Renal Insufficiency, Chronic; Severity of Illness Index; Sulfonamides; Sustained Virologic Response | 2019 |
6 other study(ies) available for leucine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
Topics: Animals; Canagliflozin; Diabetes Mellitus, Type 2; Glucose; Humans; Inflammasomes; Leucine; Mice; Myocytes, Smooth Muscle; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Osteogenesis; Pyrin Domain; Rats; Renal Insufficiency, Chronic; Sodium; Vascular Calcification; X-Ray Microtomography | 2023 |
Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification.
Topics: Animals; Atherosclerosis; Endothelial Cells; Glycoproteins; Humans; Leucine; Mice; Mice, Knockout; Myocytes, Smooth Muscle; Plaque, Atherosclerotic; Renal Insufficiency, Chronic; Vascular Calcification | 2023 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Proline; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Retrospective Studies; Sulfonamides; Sustained Virologic Response; Taiwan | 2020 |
Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R).
Topics: Amides; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Benzofurans; Carbamates; Cyclopropanes; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Lactams, Macrocyclic; Leucine; Proline; Prospective Studies; Pyrrolidines; Quinoxalines; Registries; Renal Insufficiency, Chronic; Ribavirin; Sulfonamides; Sustained Virologic Response | 2022 |
More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Liver Cirrhosis; Peritoneal Dialysis; Proline; Pyrrolidines; Quinoxalines; Renal Insufficiency, Chronic; Sulfonamides | 2020 |
Branched chain amino acid profile in early chronic kidney disease.
Topics: Adult; Amino Acids, Branched-Chain; Biomarkers; C-Reactive Protein; Case-Control Studies; Disease Progression; Humans; Hypoalbuminemia; India; Inflammation Mediators; Leucine; Malnutrition; Middle Aged; Nutritional Status; Renal Insufficiency, Chronic; Serum Albumin; Valine | 2012 |